絞り込み

16399

広告

Improving community prescribing of post-fracture denosumab after discharge.

著者 Wood H , Lewis H , Ward R , Solanki T , Fernando P
Br J Hosp Med (Lond).2017 Jan 02 ; 78(1):20-22.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (42view , 0users)

Full Text Sources

Medical

In the UK, denosumab is usually started by hospital clinicians and continued by primary care physicians in the community, but in the authors' region denosumab is a 'green light' drug, only prescribed by the primary care team. The authors suspected that a proportion of patients who were recommended to start the drug after a neck of femur fracture were not receiving this on discharge. They aimed to improve the prescribing of denosumab by implementing a quality improvement project.
PMID: 28067568 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード